Nigeria is set to receive Lenacapavir, a highly effective HIV prevention drug that has shown 100% effectiveness in clinical trials, according to the National Agency for the Control of AIDS (NACA). The agency has secured regulatory approval and is advancing preparations for the introduction and rollout of Lenacapavir as pre-exposure prophylaxis (PrEP).
“The Government of Nigeria (GON) is advancing preparations for the introduction and rollout of Lenacapavir (LEN) as Pre-Exposure Prophylaxis (PrEP). This is part of Government’s commitment to strengthen HIV prevention and accelerate progress toward epidemic control,” NACA stated.
ATTENTION: Click “HERE” to join our WhatsApp group and receive News updates directly on your WhatsApp!
Lenacapavir is a long-acting HIV prevention drug that significantly reduces the risk of infection. The introduction of Lenacapavir is expected to enhance HIV prevention efforts in Nigeria.